Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes

Veterinary Immunology and Immunopathology

Volumn 141, Issue 1-2, 2011, Pages 92-99

  Cook, Vanessa L ^a   Holcombe, Susan J ^a   Gandy, Jeffrey C ^a   Corl, Christine M ^a   Sordillo, Lorraine M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Equine; Ethyl pyruvate; LPS; Monocytes

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN; CASPASE 3; CASPASE 7; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYTOKINE; ELONGATION FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SEQUENCE; HORSE; IMMUNE RESPONSE; INFLAMMATION; MONOCYTE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CASPASE 3; CASPASE 7; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HORSES; INFLAMMATION; LIPOPOLYSACCHARIDES; MONOCYTES; PYRUVATES;

EQUIDAE;

EID: 79953320579     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.02.012     Document Type: Article

References (41)

1. Barton M.H., Bruce E.H., Moore J.N., Norton N., Anders B., Morris D.D. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Am. J. Vet. Res. 1998, 59:792-797.
2. Barton M.H., Collatos C., Moore J.N. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet. J. 1996, 28:382-389.
3. Barton M.H., Parviainen A., Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet. J. 2004, 36:397-401.
4. Baskett A., Barton M.H., Norton N., Anders B., Moore J.N. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am. J. Vet. Res. 1997, 58:1291-1299.
5. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J. Bioenerg. Biomembr. 1997, 29:355-364.
6. Corl C.M., Robinson H.R., Contreras G.A., Holcombe S.J., Cook V.L., Sordillo L.M. Ethyl pyruvate diminishes the endotoxin-induced inflammatory response of bovine mammary endothelial cells. J. Dairy Sci. 2010, 93:5188-5199.
7. Fessler J.F., Bottoms G.D., Coppoc G.L., Gimarc S., Latshaw H.S., Noble J.K. Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine Vet. J. Suppl. 1989, 24-28.
8. Figueiredo M.D., Salter C.E., Hurley D.J., Moore J.N. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide. Vet. Immunol. Immunopathol. 2008, 121:275-280.
9. French N.P., Smith J., Edwards G.B., Proudman C.J. Equine surgical colic: risk factors for postoperative complications. Equine Vet. J. 2002, 34:444-449.
10. Gangur V., Birmingham N.P., Thanesvorakul S. Chemokines in health and disease. Vet. Immunol. Immunopathol. 2002, 86:127-136.
11. Han Y., Englert J.A., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J. Pharmacol. Exp. Ther. 2005, 312:1097-1105.
12. Hollenbach M., Hintersdorf A., Huse K., Sack U., Bigl M., Groth M., Santel T., Buchold M., Lindner I., Otto A., Sicker D., Schellenberger W., Almendinger J., Pustowoit B., Birkemeyer C., Platzer M., Oerlecke I., Hemdan N., Birkenmeier G. Ethyl pyruvate and ethyl lactate down-regulate the production of pro-inflammatory cytokines and modulate expression of immune receptors. Biochem. Pharmacol. 2008, 76:631-644.
13. Johansson A.S., Palmblad J. Ethyl pyruvate modulates adhesive and secretory reactions in human lung epithelial cells. Life Sci. 2009, 84:805-809.
14. Kelmer G., Doherty T.J., Elliott S., Saxton A., Fry M.M., Andrews F.M. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse. Equine Vet. J. 2008, 40:358-363.
15. King J.N., Gerring E.L. Detection of endotoxin in cases of equine colic. Vet. Rec. 1988, 123:269-271.
16. Lorente J.A., Marshall J.C. Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 2005, 24(Suppl. 1):107-119.
17. Momin A., McNaughton P.A. Regulation of firing frequency in nociceptive neurons by pro-inflammatory mediators. Exp. Brain Res. 2009, 196:45-52.
18. Moore J.N., Norton N., Barton M.H., Hurley D.J., Reber A.J., Donovan D.C., Vandenplas M.L., Parker T.S., Levine D.M. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine Vet. J. 2007, 39:243-248.
19. Nieto J.E., MacDonald M.H., Braim A.E., Aleman M. Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine Vet. J. 2009, 41:717-719.
20. Parsons C.S., Orsini J.A., Krafty R., Capewell L., Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J. Am. Vet. Med. Assoc. 2007, 230:885-889.
21. Parviainen A.K., Barton M.H., Norton N.N. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am. J. Vet. Res. 2001, 62:72-76.
22. Poulin Braim A.E., MacDonald M.H., Bruss M.L., Grattendick K.J., Giri S.N., Margolin S.B. Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia. Am. J. Vet. Res. 2009, 70:1031-1042.
23. Sappington P.L., Han X., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J. Pharmacol. Exp. Ther. 2003, 304:464-476.
24. Schroeder, E.L., Holcombe, S.J., Cook, V.L., James, M.D., Gandy, J.C., Hauptman, J.G., Sordillo, L.M., 2011. Preliminary safety and biological efficacy studies of ethyl pyruvate in normal mature horses. Equine Vet. J., in press.
25. Sims C.A., Wattanasirichaigoon S., Menconi M.J., Ajami A.M., Fink M.P. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit. Care Med. 2001, 29:1513-1518.
26. Song M., Kellum J.A., Kaldas H., Fink M.P. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J. Pharmacol. Exp. Ther. 2004, 308:307-316.
27. Steverink P.J., Salden H.J., Sturk A., Klein W.R., van der Velden M.A., Nemeth F. Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders. Vet. Q. 1994, 16(Suppl. 2):S117-S121.
28. Su F., Wang Z., Cai Y., Remmelink M., Vincent J.L. Beneficial effects of ethyl pyruvate in septic shock from peritonitis. Arch. Surg. 2007, 142:166-171.
29. Sun W.C., Berghaus L.J., Moore J.N., Hurley D.J., Vandenplas M.L., Thompson R., Linden J. Lipopolysaccharide and TNF-alpha modify adenosine A(2A) receptor expression and function in equine monocytes. Vet. Immunol. Immunopathol. 2009.
30. Suzuki K., Matsui Y., Miura Y., Sentsui H. Equine coronavirus induces apoptosis in cultured cells. Vet. Microbiol. 2008, 129:390-395.
31. Tetens J., Moore R.M., Hosgood G.L., Eades S.C., Keowen M.L., Horohov D.W. Effects of infusion of adenosine triphosphate-magnesium chloride on cardiopulmonary and clinicopathologic variables, cytokine activity, and endothelin concentration in horses administered a low dose of endotoxin. Am. J. Vet. Res. 2004, 65:225-237.
32. Thoefner M.B., Ersboll A.K., Jensen A.L., Hesselholt M. Factor analysis of the interrelationships between clinical variables in horses with colic. Prev. Vet. Med. 2001, 48:201-214.
33. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38:1654-1661.
34. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12351-12356.
35. van Zoelen M.A., Bakhtiari K., Dessing M.C., van't Veer C., Spek C.A., Tanck M., Meijers J.C., van der Poll T. Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells. Thromb. Haemost. 2006, 96:789-793.
36. van Zoelen M.A., de Vos A.F., Larosa G.J., Draing C., von Aulock S., van der Poll T. Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo. Shock 2007, 28:570-575.
37. Venkataraman R., Kellum J.A., Song M., Fink M.P. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 2002, 18:507-512.
38. Werners A.H., Bull S., Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet. J. 2005, 37:371-383.
39. Winchell W.W., Hardy J., Levine D.M., Parker T.S., Gordon B.R., Saal S.D. Effect of administration of a phospholipid emulsion on the initial response of horses administered endotoxin. Am. J. Vet. Res. 2002, 63:1370-1378.
40. Yamamoto T., Kajikawa O., Martin T.R., Sharar S.R., Harlan J.M., Winn R.K. The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. J. Immunol. 1998, 161:5704-5709.
41. Yu D.H., Noh D.H., Song R.H., Park J. Ethyl pyruvate down-regulates tumor necrosis factor alpha, interleukin (IL)-6 and up-regulates IL-10 in lipopolysaccharide-stimulated canine peripheral blood mononuclear cells. J. Vet. Med. Sci. 2010, 72:1379-1381.